Skip to content

The effect of Lavandula angustifolia extract on gastric residual volume

The effect of Lavandula angustifolia extract on gastric residual volume in mechanically ventilated patients hospitalized in the Intensive Care Units

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250222064802N1
Enrollment
60
Registered
2025-03-07
Start date
2025-03-21
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases of the digestive system. Other diseases of digestive system

Interventions

Intervention 1: This comprehensive protocol details the procedures and data collection methods employed in both the control and intervention groups.Data Collection and Monitoring: A standardized check
(2) Ventilator settings information (2 questions)
(3) Vital signs recording
and (4) Measurement of gastric residual volume (GRV) performed by the research personnel. All patients will receive standard medical and nursing care, tailored to their individual conditions and physi

Sponsors

Gonabad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Patients admitted to the intensive care unit (ICU) after 24 hours of their admission 2.Written informed consent from the patient’s legal guardian for participation in the study 3.Age between 18 and 60 years 4.Stable hemodynamic conditions 5.No history of drug addiction to narcotics or strong analgesics based on documentation and questioning of the patient’s legal guardian 6.No sensitivity to lavender extract, as determined by questioning the patient’s legal guardian 7.Being connected to a ventilator 8.Having a nasogastric or orogastric tube 9.Not using prokinetic drugs such as metoclopramide and erythromycin within 8 hours before the intervention 10.No history of recent (10 days or less) stomach or gastrointestinal system ulcers or surgery 11.Not pregnant 12.No history of hypothyroidism, hypoglycemia, or occurrence of paralytic ileus 13.Not using laxatives 14.GCS = 7 (Glasgow Coma Scale score of 7 or less) 15.No history of any digestive diseases.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
1.Residual gastric volume. Timepoint: Measurement of gastric residual volume before the intervention and 3.6 hours after the intervention for one week. Method of measurement: 60cc gavage syringe.

Secondary

MeasureTime frame
Blood pressure. Timepoint: In each shift and for one week before the intervention. Method of measurement: Electronic blood pressure monitor.;Pulse. Timepoint: In each shift and for one week before the intervention. Method of measurement: Pulse oximeter device.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactEsmaeil Saburie

Gonabad University of Medical Sciences

saburie72@gmail.com+98 51 4421 0369

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026